Top-down control analysis of the cadmium effects on molluscan mitochondria and the mechanisms of cadmium-induced mitochondrial dysfunction.
Cadmium (Cd) is a toxic metal and an important environmental pollutant that can strongly affect mitochondrial function and bioenergetics in animals. We investigated the mechanisms of Cd action on mitochondrial function of a marine mollusk (the eastern oyster Crassostrea virginica) by performing a top-down control analysis of the three major mitochondrial subsystems (substrate oxidation, proton leak, and phosphorylation). Our results showed that the substrate oxidation and proton leak subsystems are the main targets for Cd toxicity in oyster mitochondria. Exposure to 12.5 μM Cd strongly inhibited the substrate oxidation subsystem and stimulated the proton conductance across the inner mitochondrial membrane. Proton conductance was also elevated and substrate oxidation inhibited by Cd in the presence of a mitochondrially targeted antioxidant, MitoVitE, indicating that Cd effects on these subsystems were to a large extent ROS independent. Cd did not affect the kinetics of the phosphorylation system, indicating that it has negligible effects on F₁, F(O) ATP synthase and/or the adenine nucleotide transporter in oyster mitochondria. Cd exposure altered the patterns of control over mitochondrial respiration, increasing the degree of control conferred by the substrate oxidation subsystem, especially in resting (state 4) mitochondria. Taken together, these data suggest that Cd-induced decrease of mitochondrial efficiency and ATP production are predominantly driven by the high sensitivity of substrate oxidation and proton leak subsystems to this metal.
Kurochkin
Ilya O
IO
Dept. of Biology, Univ. of North Carolina at Charlotte, 28223, USA.
Etzkorn
Markus
M
Buchwalter
David
D
Leamy
Larry
L
Sokolova
Inna M
IM
D000255:Adenosine Triphosphate / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002104:Cadmium / Q000494:pharmacology*; D049896:Crassostrea / Q000502:physiology*; D008928:Mitochondria / Q000187:drug effects* / Q000502:physiology*; D023421:Models, Animal; D009943:Organophosphorus Compounds / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D017382:Reactive Oxygen Species / Q000378:metabolism; D014451:Ubiquinone / Q000494:pharmacology
D000975:Antioxidants; C478642:MitoVit E; D009943:Organophosphorus Compounds; D017382:Reactive Oxygen Species; D002104:Cadmium; D014451:Ubiquinone; D000255:Adenosine Triphosphate